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Abstract
Background: Essential oils (EO) obtained from twenty medicinal and aromatic plants were evaluated for their
antimicrobial activity against the oral pathogens Candida albicans, Fusobacterium nucleatum, Porphyromonas
gingivalis, Streptococcus sanguis and Streptococcus mitis.
Methods: The antimicrobial activity of the EO was evaluates by microdilution method determining Minimal
Inhibitory Concentration. Chemical analysis of the oils compounds was performed by Gas chromatography–mass
spectrometry (CG-MS). The most active EO were also investigated as to their actions on the biolfilm formation.
Results: The most of the essential oils (EO) presented moderate to strong antimicrobial activity against the oral
pathogens (MIC - Minimal Inhibitory Concentrations values between 0.007 and 1.00 mg/mL). The essential oil
from Coriandrum sativum inhibited all oral species with MIC values from 0.007 to 0.250 mg/mL, and MBC/MFC
(Minimal Bactericidal/Fungicidal Concentrations) from 0.015 to 0.500 mg/mL. On the other hand the essential oil
of C. articulatus inhibited 63.96% of S. sanguis biofilm formation. Through Scanning Eletronic Microscopy (SEM)
images no changes were observed in cell morphology, despite a decrease in biofilm formation and changes on
biofilm structure. Chemical analysis by Gas Chromatography – Mass Spectrometry (GC-MS) of the C. sativum
essential oil revealed major compounds derivatives from alcohols and aldehydes, while Cyperus articulatus and
Aloysia gratissima (EOs) presented mono and sesquiterpenes.
Conclusions: In conclusion, the crude oil from C. articulatus exhibited the best results of antimicrobial activity
e ability to control biofilm formation. The chemical analysis showed the presence of terpenes and monoterpenes
such as a-pinene, a-bulnesene and copaene. The reduction of biofilms formation was confirmed from SEM images.
The results of this research shows a great potential from the plants studied as new antimicrobial sources.
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Background
The oral cavity is the habitat of several kinds of microor-
ganisms, which form a complex community structure that
can adhere to the teeth surface or to mucosal epithelial
forming biofilms [1]. Microbial biofilms are communities
formed when single cell microorganisms become firmly
adhered to a solid surface covered by an extracellular
polysaccharide matrix, and can be formed from multiple or
single microbial species [2].
Oral biofilm acquires new microbial species in each
stage of its development, including Lactobacillus casei,
Streptococcus sanguis, S. mutans, S. mitis and S. sobrinus,
which due their pathogenicity could damage the enamel and
gum tissue [3]. Diseases appear in this micro-environment
when there is a lack of equilibrium in the ecosystem of the
bacterial biofilm formed [4], and thus the mechanical
removal of the biofilm is an important factor to prevention
of caries and periodontal diseases. Since biofilm is an
organized association, able to adhere to teeth and causing
pathological alterations in oral cavity, its disaggregation is
indicated as soon as possible [5]. Considering the importance
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of this dissociation, it is important to associate both
chemical and mechanical procedures in order to control
its formation [6].
Antimicrobial substances such as chlorhexidine diglu-
conate has been considered as golden standard when
compared to other chemical agents used in dentistry,
due its capacity to avoid dental biofilm formation [7].
The main advantage of using chlorhexidine is its wide
antimicrobial spectrum, acting on both Gram-positive
and Gram-negative microorganisms, and its prolonged
and continuous effect even in the presence of blood and
other body fluids [8]. However, the prolonged use of
chlorhexidine can cause mucous peeling, stains on the
teeth, alterations in the sense of taste, compromising of
the wounds healing and reduction of fibroblast adhesion
to radicular surfaces [9]. Thus a potential antimicrobial
adjuvant alternative with less side-effects would be of
great value acting on oral affections.
An increasing interest in natural products as a source
of new bioactive molecules has been observed in the
literature [10]. These include essential oils (EOs) from
medicinal and aromatic plants, products of their secon-
dary metabolism. They are characterized as having a very
diverse composition derived mainly from two different
groups of compounds, the terpenoids (monoterpenes and
sesquiterpenes) and phenylpropanoids [11]. These com-
pounds come from different precursors of primary metab-
olism and are synthesized through different pathways
conferring antimicrobial and antifungal properties [12]. The
antimicrobial properties of EOs against a wide variety
of bacteria and fungi have been shown, including oral
pathogens [10,13-15]. Thus, the use of plants as alterna-
tive medicine has gained the attention of the scientific
community, since this is a promising field for the treat-
ment of pathogens, including those related to the oral
cavity. Considering the increased interest in the use
of natural products as alternative antimicrobial sub-
stances, the aim of this work was to evaluate the ac-
tivity of EOs from twenty medicinal plants against
both planktonic cells and biofilms of oral pathogens
as well the chemical composition from the most ac-
tive oils by GC/MS – Gas Chromatography/Mass Spec-
trometry analysis and, the possible morphological cells
alterations by SEM – Scanning Electronic Microscopy.
Methods
Microorganisms
The following oral pathogens were studied: Candida
albicans CBS 562 from “Centraalbureau voor Schimmel-
cultures” and bacteria Streptococcus sanguis ATCC 10556,
Table 1 Medicinal and aromatic plants from CPMA – “Collection of Medicinal and Aromatic Plants” - CPQBA/UNICAMP
selected for this study
Medicinal Species Family Popular Name Source No. CPMA No. Voucher* Popular use
Aloysia gratissima (Giil & Hook) Verbenaceae Brazilian lavender leaf 714 UEC 121.393 Digestive antispasmodic
Aloysia triphylla (L’Hér.) Britton Verbenaceae Aloisia leaf 274/700 UEC 121.412 Sedative, antispasmodic
Alpinia speciosa (Pers.) Burtt & Smith Zingiberaceae Colony root 447 UEC 145.185 Antimicrobial
Baccharis dracunculifolia DC. Asteraceae Broom weed leaf 1841 - Tonic, eupeptic, antipyretic
Cinnamomun zeilanicus Blume Lauraceae Cinnamon leaf 455 IAC 19624 Carminative, antispasmodic
Coriandrum sativum L. Apiaceae Coriander leaf 664 - Antimicrobial,antifungal
Cymbopogon citratus (DC) Stapf Poaceae Lemon grass leaf 503 UEC 85.210 Sedative, analgesic, anti-cough
Cymbopogon martini (Roxb.) J.F. Watson Poaceae Palmarosa leaf 354 UEC 127.115 Antiseptic, antifungal
Cymbopogon winterianus Jowitt. Poaceae Lemon verbena leaf 712 UEC 121.414 Repellent, insecticide
Cyperus articulatus Vahl Cyperaceae Piprioca bulbs 222 UEC 121.396 Anti-inflammatory
Elyonurus muticus Spreng Poaceae Agripalma leaf 1701 UEC 20.580 Antibacterial
Eugenia florida DC. Myrtaceae Guamirin-cereja leaf 1685 IAC 49207 Anti-inflammatory
Eugenia uniflora L Myrtaceae Pitanga leaf 1816 - Anti-hypertensive, diuretic
Lippia alba (Mill) N.E. Brown Verbenaceae False lemon balm leaf 467/509 UEC 121.413 Treatment of migraines
Lippia sidoides Cham. Verbenaceae Rosemary leaf 398/399 - Bactericide, fungicide
Mentha x piperita L. Lamiaceae Mint leaf 560 UEC 127.110 Antifungal, antibacterial
Mikania glomerata Spreng Asteraceae Guaco leaf 766 UEC 102.047 Anti-inflammatory, bronchodilator
Siparuna guianenses Aubl. Monimiaceae Wild lemon leaf 2025 - Tranquilizer, diuretic
Syzygium aromaticum (L.) Merr. &
L. M. Perry
Myrtaceae Cloves leaf 455 IAC 19624 Seasoning, antibacterial
Ziziphus joazeiro mart Rhamnaceae Juazeiro fruit leaf 2119 - Astringent, Anti-inflammatory
*Deposited in the herbarium of species with no voucher number are being registered yet.
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Streptococcus mitis ATCC 903, Porphyromonas gingivalis
ATCC 33277 and Fusobacterium nucleatum ATCC 25586
from American Type Culture Collection. The microorgan-
isms were stored at −70°C in Sabouraud Dextrose Broth
(SDB, Merck® - C. albicans) and Mueller-Hinton Broth
(Difco® - bacteria) with 15% glycerol. It was considered the
oxygen exigencies of each microorganism (C. albicans -
aerobiosis, S. mitis and S. sanguis microaerophilie and
F. nucleatum and P. gingivalis anaerobiosis) to choose
bacteria growth conditions.
Plant material
Twenty medicinal and aromatic species choose for
this study were belonging to “Collection of Medicinal
and Aromatic Plants” - CPMA of the Research Center
for Chemistry, Biology and Agriculture (CPQBA),
University of Campinas (UNICAMP), Campinas, SP,
Brazil (http://www.cpqba.unicamp.br/), with the vouchers
numbers indicated in Table 1. Samples were collected in
spring/summer from November 2009 to January 2011, in
the morning after dew point. The exsiccates from plant
material used in this study are deposited in the herbarium
of the Institute of Biology at UNICAMP - UEC and were
identified by Dr. Washington Marcondes Ferreira Neto
(curator). The species were deposited in the.
EO extraction
The EOs were obtained from 100 g of fresh plant parts by
water distillation for 3 h using a Clevenger-type system.
After completion of this process, the system was cooled
and the aqueous phase collected followed by washing of
all the Clevenger apparatus with dichloromethane (50 ml)
to obtain the EOs.The pooled organic phases were dried
with sodium sulfate, filtered, and the solvent evaporated
until dryness. The oil samples were stored at −25°C in
sealed glass vials [16].
Fractionation of EOs
For the fractionation, the oils were selected based on
criteria such as good antimicrobial activity (MIC until
0.5 mg/mL [17], oil yield (>0.5%, except for C. sativum
and M. glomerata), seasonal cultivation of the plants and
Table 2 Oil yield and antimicrobial activity of the EOs studied against oral pathogens (MIC/MBC/MFC – mg/mL)
Microorganisms
Medicinal species % Yield (%) C. albicans
CBS 562
F. nucleatum
ATCC 25586
P. gingivalis
ATCC 33277
S. sanguis
ATCC 10556
S. mitis
ATCC 903
MIC MFC MIC MBC MIC MBC MIC MBC MIC MBC
Aloysia gratissima (Aff & Hook).Tr 1.10 0.015 0.062 0.125 0.250 0.125 0.125 0.500 1.000 0.250 0.250
Aloysia triphylla (L’Hér.) Britton 0.27 0.015 0.062 0.125 0.250 0.250 0.250 0.500 1.000 0.500 0.500
Alpinia speciosa (Pers.) Burtt & Smith 0.22 0.007 0.062 0.125 0.125 0.125 0.250 0.500 * 0.500 *
Baccharis dracunculifolia DC. 0.80 0.250 0.500 0.125 0.250 0.125 0.125 0.500 0.500 0.250 0.250
Cinnamomun zeilanicus Blume 0.22 0.007 0.007 0.250 0.250 0.250 0.250 0.500 1.000 0.500 0.500
Coriandrum sativum L. 0.29 0.007 0.015 0.015 0.125 0.125 0.125 0.250 0.500 0.062 0.125
Cymbopogon citratus (DC) Stapf 1.13 0.015 0.125 0.250 0.250 0.250 0.250 0.500 * 0.250 0.500
Cymbopogon. martini (Roxb.) J.F. Watson 0.59 0.015 0.125 0.125 0.250 0.250 0.250 0.500 * 0.250 0.250
Cymbopogon. winterianus Jowitt. 1.48 0.015 0.125 0.125 0.250 0.250 0.500 0.500 * 0.250 0.500
Cyperus articulatus L. 0.50 0.125 0.500 0.250 0.250 0.250 0.250 0.250 0.500 0.250 0.500
Elyonurus muticus Spreng. 0.61 0.250 * 0.250 0.500 0.250 0.250 0.500 1.000 0.500 *
Eugenia florida DC. 0.34 0.125 * 0.125 0.250 0.125 * 0.125 0.250 0.500 0.500
Eugenia uniflora L 0.76 0.250 * 0.125 0.125 0.250 0.250 0.500 0.500 0.500 0.500
Lippia alba (Mill) N.E. Brown 0.30 0.250 0.500 0.125 0.125 0.250 0.250 0.250 1.000 0.250 *
L. sidoides Cham. 4.67 0.250 0.500 0.125 0.125 0.250 0.250 0.125 0.500 0.250 *
Mentha piperita L. 2.22 0.500 * 0.250 0.250 0.250 * 0.500 0.500 0.500 0.500
Mikania glomerata Spreng 0.40 0.250 0.250 0.250 0.500 0.500 * 0.062 0.125 0.125 0.125
Siparuna guianenses Aubl 0.29 0.125 0.250 0.062 0.250 0.062 0.125 0.250 1.000 0.125 0.250
Syzygium aromaticum (L.) Merr. & L. M. Perry 0.46 0.500 0.500 0.250 0.250 0.250 0.250 0.500 1.000 0.500 0.500
Ziziphus joazeiro mart 0.46 1.000 * 0.250 0.500 0.250 0.250 0.500 1.000 0.500 0.500
Nystatin - 0.007 0.015 - - - - - - - -
Chlorhexidine digluconate - - 0.015 0.015 0.015 0.125 0.015 0.015 0.015 0.125
*Fungicidal/bactericidal action: MIC > 1 mg/mL.
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potential production on commercial scale. The Eos (500 mg)
were fractioned on a dry column (acetate cellulose 2 cm X
20 cm) prepared with silica gel 60 (20 gr / 0,063-0,200 mm)
(Merck) by direct application onto the packed column,
followed by elution. Dichloromethane was previously defined
as mobile phase for the fractionation of the oils by TLC
(Thin-Layer Chromatography) analysis of each EO
using different eluents. After elution, the column was
cut in different parts for each EO, and the fractions were
individually transferred to appropriate flasks, dissolved in
dichloromethane and re-analyzed by TLC. Fractions with
similar chemical pattern were grouped resulting in fractions
named F1, F2, F3 and F4 in order of increasing polarity.
The resulting fractions were filtered under vacuum and the
silica residue extracted with dichloromethane [16]. The
fractions were analyzed using Gas chromatography coupled
to mass spectrometry (GC-MS) and then used anti-
microbial assays. All chemical wastes produced in the
present study were treated according to the approval
of Environmental Ethics Committee of UNICAMP
(322/2009).
Chemical Constituents of EOs and fractions - Gas
chromatography–mass spectrometry (GC-MS)
The volatile constituents of the EOs oils were determined
using a Hewlett-Packard 6890 gas chromatograph, equipped
with a HP-5975 mass selective detector and HP-5MS capil-
lary column (30 m× 0.25 mm× 0.25 μm diameter). GC and
GC–MS were carried out using split (1:30) injection, with
injector temperature set at 220°C, column at 60°C, a heating
Table 3 Antimicrobial activity of the crude EO and their fractions against oral pathogens (MIC/MBC/MFC – mg/mL)
Microorganisms
Medicinal species % Yield fraction C. albicans
CBS 562
F. nucleatum
ATCC 25586
P. gingivalis
ATCC 33277
S. sanguis
ATCC 10556
S. mitis
ATCC 903
MIC MFC MIC MBC MIC MBC MIC MBC MIC MBC
EO A. gratissima 0.015 0.062 0.125 0.250 0.125 0.125 0.500 1.000 0.250 0.250
F1AG 25.70 0.500 1.000 0.500 0.500 0.250 0.500 0.500 1.000 0.250 0.500
F2AG 11.12 0.500 * 0.500 0.500 0.250 0.500 0.500 1.000 0.500 0.500
F3AG 26.94 0.500 1.000 0.250 0.500 0.250 0.500 0.500 0.500 0.250 0.500
F4AG 16.48 0.125 * 0.062 0.250 0.125 0.500 0.125 0.125 0.125 0.125
EO C. sativum 0.007 0.015 0.015 0.125 0.125 0.125 0.250 0.500 0.063 0.125
F1CS 24.88 0.500 1.000 0.250 0.250 0.125 0.500 0.500 0.500 0.500 0.500
F2CS 39.20 0.250 1.000 0.125 0.250 0.125 0.500 0.500 0.500 0.250 1.000
F3CS 15.20 O.250 1.000 0.250 0.250 0.125 0.500 0.500 * 0.250 1.000
F4CS 9.20 0.250 1.000 * * 0.500 1.000 0.500 1.000 0.500 *
EO C. articulatus 0.125 0.500 0.250 0.250 0.250 0.250 0.250 0.500 0.250 0.500
F1CA 9.20 0.250 1.000 0.250 * 0.125 0.250 * * 0.500 *
F2CA 9.41 0.250 * 0.250 0.250 0.500 1.000 1.000 * 0.500 *
F3CA 24.51 0.250 * 0.250 0.250 0.250 1.000 0.500 1.000 0.250 0.500
F4CA 26.16 0.250 1.000 0.125 0.250 0.250 0.250 0.250 0.500 0.250 0.250
EO M. glomerata 0.250 0.250 0.250 0.500 0.500 * 0.062 0.125 0.125 0.125
F1MG 42.80 0.250 * 0.250 0.500 0.250 0.500 * * 0.500 *
F2MG 14.00 0.250 0.500 0.250 * 0.500 0.500 * * 0.500 1.000
F3MG 7.20 0.250 1.000 0.250 * 0.250 0.500 * * * *
F4MG 2.56 0.250 1.000 0.250 * 0.250 0.250 0.250 1.000 0.250 0.500
EO L. sidoides 0.250 0.500 0.125 0.125 0.250 0.250 0.125 0.500 0.250 *
F1LS 31.96 0.250 * 0.062 0.250 0.250 * 0.500 0.500 0.250 *
F2LS 43.12 0.500 1.000 0.031 0.250 0.125 * 0.125 0.250 0.125 0.125
F3LS 13.34 0.500 0.500 0.062 0.250 0.250 0.500 0.250 0.250 0.125 0.250
F4LS 4.96 0.250 1.000 0.125 0.250 0.250 * 0.250 0.500 0.250 *
Nystatin/ 0.007 0,015 - - - - - - - -
chlorhexidine digluconate - - 0.015 0.015 0.015 0.125 0.015 0.015 0.015 0.125
*Fungicidal/bactericidal action: MIC > 1 mg/mL ,
AG: A. gratissima, CA: C. articulatus, CS: C. sativum, MG: M. glomerata, LS: L. sidoides.
Bersan et al. BMC Complementary and Alternative Medicine 2014, 14:451 Page 4 of 12
http://www.biomedcentral.com/1472-6882/14/451
ramp of 3°C min−1 to a final temperature of 240°C, and the
MS and FID detectors set at 250°C. Helium was used as the
carrier gas at 1 mL min−1. The GC–MS electron ionization
system was set at 70 eV. A sample of the EO was dissolved
in ethyl acetate for the analyses. Retention indices (RI)
relative to n-alkanes were calculated by linear interpolation.
Oils components were identified by comparision of experi-
mental RI with reference data [18], by maching mass spectra
with NIST software 05® reference spectra and by injection of
authentic standards, when available.
Microbiological assays
Inocula preparation
Candida albicans, S. sanguis, S. mitis, P. gingivalis and
F. nucleatum were grown overnight at 36°C in Sabouraud
Dextrose Broth (SDB, Merck®) and Mueller-Hinton Broth
(Difco®), respectively. The inocula were prepared according
to CLSI protocols M27-A2 and M7-A6 (CLSI 2002, 2005)
[19,20]. The cells were diluted in 0.85% NaCl solution and
the suspension turbidity adjusted to 0.5 on the McFarland
scale and confirmed in a spectrophotometer (Shimadzu
UV mini 1240 Spectrophometer) at 530 nm (C. albicans)
or 625 nm (bacteria) to absorbance between 0.08-0.1
(106 cells/mL for yeast and 108 cells/mL for bacteria).
The cell suspensions were finally diluted to 104 cells/mL
for (yeast) or 106 cells/mL (bacteria).
Minimal Inhibitory Concentration (MIC) of the EOs
The MIC was determined using tissue culture microplates
(96 wells) containing 100 μL of Brain Heart Infusion
(BHI - Oxoib®), culture medium for bacteria and
Sabouraud Dextrose Broth (SDB, Merck®) for C. albicans.
The stock solutions of EOs oils and fractions were diluted
to 4 mg/mL with propylene glycol, transferred to the first
well and serial dilutions were performed to reach con-
centrations ranging from 1.0-0.00048 mg/mL. Nystatin
(Sigma® - 1%) and chlorhexidine digluconate (Sigma® -
0.12%) were used as antimicrobial standard. The inocula
(100 μL) was added to all the wells, and the plates
incubated at 36°C for 48 h in aerobic, microaerophilic
or anaerobic conditions. The MIC was defined as the low-
est concentration of the EO able to prevent the microbial
growth. The tests were performed in three independent
experiments, each one in triplicate [19,20].
Minimal Bactericidal/Fungicidal Concentration (MBC/MFC)
of the EOs
Based on the MIC results 10 μL of the cells suspension
from the wells showing no visible microbial growth and
from three wells above them were subcultured in Petri
dishes containing Sabouraud Dextrose Agar medium
(SDA- Merck®) for yeasts and Tryptic Soy Agar (TSA-
Difco®) or Blood Agar media for bacteria. The plates
were incubated at 36°C until five days in aerobic, micro-
aerophilic or anaerobic conditions. The MBC/MFC was
defined as the lowest sample concentration showing no
cell growth on the inoculated agar surface. The tests
were performed in three independent experiments,
each one in triplicate [19,20]. The EOs and fractions
antimicrobial activity was classified in strong, moderate or
weak according to Duarte et al. [17].
Biofilms assays
Mode of action of the EOs on biofilm
The method employed for biofilm studies was carried
out according to described in the antimicrobial assays
Table 4 Antimicrobial activity of the EO against biofilms (72 h) and MBC/MFC:MIC ratio
Microorganisms
Medicinal species C. albicans CBS 562 F. nucleatum ATCC 25586 P. gingivalis ATCC 33277 S. sanguis ATCC 10556 S. mitis ATCC 903
MIC MFC Ratio MIC MBC Ratio MIC MBC Ratio MIC MBC Ratio MIC MBC Ratio
A. gratissima 0.500 * ND 0.500 0.500 1:1 0.125 * ND 0.500 1.000 2:1 0.250 0.500 2:1
F4AG 0.500 * ND 0.250 1.000 4:1 0.500 * ND 0.500 0.500 1:1 0.250 * ND
C. sativum 0.250 1.000 4:1 0.250 * ND 0.500 * ND 0.500 * ND 0.500 * ND
M. glomerata 0.500 0.500 1:1 0.250 * ND 1.000 * ND 0.500 * ND 0.500 * ND
F4MG 1.000 1.000 1:1 0.500 1.000 2:1 * * ND 0.500 0.500 1:1 0.500 * ND
C. articulatus 0.250 0.250 1:1 0.250 0.500 2:1 0.250 0.500 2:1 0.250 0.500 2:1 0.500 1.000 2:1
F4CA 1.000 * ND 0.250 * ND * * ND 0.500 0.500 1:1 0.500 * ND
L. sidoides 0.500 1.000 2:1 0.500 1.000 2:1 0.500 * ND 0.250 0.500 2:1 0.500 * ND
F2LS 0.500 * ND 0.250 1.000 4:1 0.250 * ND 0.250 0.500 2:1 0.500 * ND
Nystatin 1.000 * ND - - - - - - - - - -
Chlorhexidine - - - 0.015 0.125 8:1 0.015 0.125 8:1 0.015 0.015 1:1 0.015 0.062 4:1
*Fungicidal/bactericidal action: MIC > 1 mg/mL.
ND- Not determined.
Ratio: MBC:MIC or MFC:MIC between 1:1–2:1 - bactericidal or fungicidal effect, while ratio >2:1 -a bacteriostatic or fungistatic effect.
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Table 5 Compounds identified in the active EO and fractions
Compoundsa RIb AGc CA CS MG LS F4 AG F4 CA F4 MG F2 LS
Z-3-hexen-1-ol 857 5.11
E-2-hexen-1-ol 868 2.17
Cyclohexanone 899 6.50
Nonane 901 2,70
a-pinene 933 5.72
b-pinene 977 12.01 3.52
p-cymene 1024 0.73 17.28
Limonene 1027 1.51 1.12 2.06
Linalool 1101 0.49 0.77 2.62
E-pinocarveol 1138 2.96 4.44 13.16 21.97
E-verbenol 1144 1.59 2.38 8.43
E-sabinol 1145 4.29
E-pinocamphone 1161 16.07 0.84
a-phellandrene-8-ol 1167 1.75
p-menta-1,5-dien-8-ol 1169 0.67 8.97
Z-pinocanphone 1173 6.04 0.46
p-cymen-8-ol 1186 0.51 0.93 2.97
a-terpineol 1192 0.30 0.95 2.17
Myrtenal 1195 2.37 9.18
Myrtenol 1196 1.81 2.13 5.31
Verbenone 1208 1.67 9.73
E-carveol 1220 1.06 2.29
Geraniol 1264
1-decanol 1269 33,91
E-2-decen-1-ol 1271 23,59
Geranial 1272
Thymol 1290 65.76 0.60 97.20
E-pinocarveol acetate 1299 8.19
a-copaene 1373 4.97 0.76
a-caryophyllene 1416 7.19 9.49 10.46
a-guaiene 1436 2.17
2-dodecen-1-ol 1469 13,06
g-muurolene 1477 3.79 3.39
Germacrene D 1481 38.29
b-selinene 1482 2.96
a-selinene 1491 2.46
Bicyclogermacrene 1493 4.20 7.98
a-bulnesene 1503 5.02
Elemol 1547 0.48 0.94 1.64 7.39
Germacrene B 1552 3.35
Sphatulenol 1574 1.54 3.65 3.96 4.31
Caryophyllene oxide 1578 2.60 3.41 4.28 1.85 0.55 5.63 0.50
Guaiol 1596 8.53 29.63
Isolongifolan-7-a-ol 1620 1.21 11.58
Bersan et al. BMC Complementary and Alternative Medicine 2014, 14:451 Page 6 of 12
http://www.biomedcentral.com/1472-6882/14/451
(MIC) with modifications. The inocula from cultures
were prepared at 107 cells/mL for bacteria and 105 cells/
mL for C. albicans in BHI or SDB media, respectively,
enriched with 2% sucrose. The cultures were incubated
at 36°C for 72 h under appropriate atmosphere in order
to promote microbial adherence to the bottom of the
wells. Subsequently, MIC values were confirmed and to
determine MBC/MFC, each adhered biofilm was
transferred by swab technique to the surface of blood
agar or SDA agar in petri dishes and incubated at 30°C for
until five days according to oxygen microorganisms
requirements [19,20]. The MIC/MBC/MFC values were
used to determine the MBC:MIC or MFC:MIC ratio, as
previously proposed by Hafidh et al. [21] to establish the
nature of antimicrobial effect, regard to inhibition or
killing of the tested microorganisms.
Effect of the EOs and fractions on biofilm formation
The biofilms were carried out using sterile untreated
96-well polyethylene U-bottom plates (IPT) containing the
specific medium (Sabouraud for yeast and BHI for bacteria)
enriched with 2% sucrose. The EOs and fractions were
diluted with propylene glycol (4 mg/mL), transferred to the
first well and serial dilutions were performed to reach
concentrations ranging from 1.0-0.0048 mg/mL. The 1%
Nystatin (Sigma®) and 0.12% chlorhexidine digluconate
(Sigma®) solutions were used as antibiotic standard. After
this procedure, microbial cells (1.0 × 105 cells/mL for yeasts
and 1.0 × 107 cells/mL for bacteria) were added to the wells
and the plates were incubated at 36°C for 72 h [22].
Biofilm quantification
Following biofilm formation the medium was aspirated
and no adhered cells were removed by washing the wells
twice with 200 μL of distilled water. The plates were then
dried at room temperature for 45 min. One hundred
microliters of a 0.4% crystal violet solution was added
to all the wells. After 45 min, the biofilms formed in
the bottom of the wells were washed four times with
distilled water and immediately distained with 200 μL
of 95% ethanol. After a further 45 min, 100 μL of
well solution were transferred to a well in a new plate
and the absorbance measured at 595 nm in a microplates
reader (Asys - Expert Plus). The amount of biofilm
formed was calculated by subtracting the absorbance
values from control well [23].
Scanning Electron Microscopy (SEM) of biofilms
In order to assess the integrity of the microbial cells,
biofilms were developed in a Lab-Tek TM coverslip
chambers (Nunc) as described above, and treated with
standard drugs and EOs at 1 mg/mL. The samples were
washed twice with 3% glutaraldehyde in phosphate
buffer (pH 7.4) and fixed in glutaraldehyde 0.15 M
2.5% (v/v) at room temperature for 12 h. The dehydrated
cells were submitted to sequential baths of ethanol at
concentrations of 50%, 70%, 90% and absolute ethanol
twice, until the dried at the critical point, then coated with
gold in a Metalizer and observed using a Scanning
Electron Microscope (Jeol model JSM 5600 Lv) [24].
Statistical analysis
Statistical analysis was performed with one-way ANOVA
and p-values ≤0.05 considered statistically significant.
The inhibition of biofilm formation data were compared by
Tukey test. The statistical test was run using STATISTICA®
v.8.0 (Stafsoft, USA) system software.
Table 5 Compounds identified in the active EO and fractions (Continued)
Muurola-4,10-dien-1-b-ol 1628 3.59 10.42
a-muurolol 1646 0.77 3.45
b-cadinol 1652 3.47 25.85
Bulnesol 1665 3.14 11.79
Tetradecanol 1670 2,92
E-2-tetradecen-1-ol 1674 5,46
Mustakone 1675 5.66
Ishwarone 1680 1.51 8.80
Germacra-4(15),5,10(14)-trien-1-a-ol 1684 5.13
Eudesma-4(15),7-dien-1-b-ol 1685 9.85
Others compounds identified <2% - 10.21 7.58 8.04 8.32 - 6.55 7.39 3.77 2.31
Total 92.35 63.05 97.73 87.39 100 86.04 85.18 90.56 99.80
aMw =molecular weight;
bRI = retention índex;
cResults expressed as % of area. AG: A. gratissima, CA: C. articulatus, CS: C. sativum, MG: M. glomerata,
LS: L. sidoides, F4MG: F4 M. glomerata, F4CA: F4 C. articulatus, F4AG: F4 A. gratissima, F2LS: F2 L. sidoides.
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Results and discussion
Oil and fractions yields
The EOs and fractions yields are presented in Tables 2
and 3, respectively, relative to mass of dry plant material.
The highest oil yields were obtained from L. sidoides
(4.67%), M. piperita (2.22%), C. winterianus (1.48%), C.
citratus (1.13%) and A. gratissima (1.10%).
Antimicrobial assays
The results obtained for MIC/MBC/MFC of the EOs
against the oral microorganisms are shown in Table 2.
According to Duarte et al. [17], the EOs presented
strong to moderate antimicrobial activity against
planktonic cells, with MIC values between 0.007 and
1.00 mg/mL. The highest activities were observed for
A. speciosa, C. sativum and C. zeilanicus EOs against
C. albicans (0.07 mg/mL). Coriandrum sativum oil
inhibited F. nucleatum and S. mitis at lowest MIC
values (0.015 mg/mL and 0.062 mg/mL, respectively)
compared with the other oils tested. S. guianenses and M.
glomerata oils inhibited, respectively, the growth of P.
gingivalis and S. sanguis at 0.062 mg/mL.
According to the criteria previously mentioned, the oils
from A. gratissima (AG), C. articulatus (CA), C. sativum
(CS), L. sidoides (LS) and M. glomerata (MG) were frac-
tionated and the fractions were submitted to antimicrobial
assays. The MIC/MBC/MFC results from crude oils (EO)
and fractions are shown in Table 3. The highest inhibitory
and bactericidal effects presented by the fractions were
observed for F2LS (Fraction 2 from L. sidoides) against F.
nucleatum and S. mitis and for F1CA (fraction 1 from C.
articulatus) and F4AG (fraction 4 from A. gratissima)
against P. gingivalis and S. sanguis, respectively. However,
all the fractions presented similar or lower activity than
the crude oil against the microorganisms suggesting a syn-
ergistic action from the compounds present in crude oil.
The marked activity found for some oils in the present
study was previously verified for bacteria such as Bacillus
megaterium, B. cereus, S. piogenes, Escherichia coli and
Proteus mirabilis (C. articulatus) and standards or clinical
isolates of Candida spp (C. sativum) [25,26]. The oil from
L. sidoides obtained in this study inhibited S. mitis and S.
sanguis at MIC values higher than those observed by
Botelho et al. [27] in an analogous study.
Mode of action of the EOs and fractions on biofilm
The results of MIC/MBC/MFC for the biofilms as well as
the MBC/MFC:MIC ratio of the most active crude oils
and fractions are shown in Table 4. The ratio calculation
was adapted from Hafidh et al. [21]. According to the re-
sults, C. articulatus EO stood out, inhibiting all investi-
gated species with the lowest MIC/MBC values. Similar
activities were observed for the crude oil and the F2LS
from L. sidoides against S. sanguis, and for A. gratissima
oil against S. mitis biofilm. As expected, planktonic cells
from all strains studied were more susceptible to the EOs
(Table 2) when compared to biofilm (Table 4) as observed
in previous studies to a great variety of antimicrobial agents
[28,29]. Chandra [30] observed that antifungal agents used
against C. albicans biofilms were much less active than
against planktonic cells, and that the concentrations
required to reach 50% inhibition of the metabolic activity
were around 5 to 8 times higher. Also, Eucalyptus oil
and its major component 1,8-cineole, when employed
alone or combined with chlorhexidine digluconate against
biofilms from several microorganisms cultures including
C. albicans, showed better activities against planktonic
cells [31]. The results confirm the effective action of
Table 6 Inhibition of biofilm formation (%) of the oral microorganisms in the presence of the EOs and fractions at
1 mg/mL
Microorganisms
Medicinal species C .albicans
CBS 562
F. nucleatum
ATCC 25586
P. gingivalis
ATCC 33277
S. sanguis
ATCC 10556
S. mitis
ATCC 903
EO A .gratissima 12.31 f 55.83 d 39.12 a 60.83 a,b 9.00 a
F4AG 19.23 d,e 56.46 d 30.88 b 58.13b,c 8.50 a
EO C. sativum 23.08 c,d 55.83 d 39.71 a 58.33 a,b,c 1.50 b
EO M. glomerata 22.69 c,d 58.96 c 40.00 a 54.79 c 1.00 b
F4MG 20.77d,e 60.83 b 37.94 a 60.63 a,b,c 0.00 c
EO C. articulatus 28.08 a,b 61.67 a,b 43.53 a 63.96 a 5.00 a,b
F4CA 25.77 a,b,c 61.25 a,b 39.41 a 61.67 a,b 2.50 b
EO L. sidoides 16.55 e,f 58.33 c 12.94 c 58.13 a,b,c 5.50 a,b
F2LS 23.85 b,c,d 62,29 a 44.41 a 42.71 d 0.00 c
Nystatin/ 29.62 a _ _ _ _
Chlorhexidine digluconate _ 55.42 d 37.65 a 57.08 c 1.50 b
AG: A. gratissima, CA: C. articulatus, CS: C. sativum, MG: M. glomerata, LS: L. sidoides. Values of 0.00 indicates any inhibition on biofilm formation.
Values in the same column with different letters (a-f) are significantly different (p≤0,05) by Tukey Test.
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Table 7 Biofilm Inhibition (%) of the oral microorganisms in the presence of C. articulatus and A. gratissima EO
Microorganism
Concentration C .albicans CBS 562 F. nucleatum ATCC 25586 P. gingivalis ATCC 33277 S. sanguis ATCC 10556 S. mitis ATCC 903
C. articulatus Nystatin C. articulatus Chlorhexidine C. articulatus Chlorhexidine C. articulatus Chlorhexidine A. gratissima Chlorhexidine
1 28.08 29.62 61.67 55.42 43.53 37.65 63.96 57.08 9.00 1.50
0.500 14.23 28.72 54.79 56.46 32.35 37.94 58.96 46.46 0.00 3.50
0.250 22.69 20.77 60.42 55.21 28.24 35.59 54.17 55.83 0.00 0.00
0.125 19.23 27.69 57.50 55.42 0.00 39.12 23.13 57.92 0.00 0.00
0.062 21.54 23.08 49.17 53.54 0.00 37.06 7.29 56.25 0.00 0.00
0.031 19.23 21.15 44.38 55.83 0.00 29.41 10.02 56.04 0.00 0.00
0.015 19.62 13.08 40.21 55.21 0.00 13.82 10.63 53.54 0.00 0.00
0.007 16.92 16.15 31.67 42.50 0.00 1.76 4.38 51.46 0.00 0.00
0.003 14.62 0.00 0.00 52.92 0.00 0.00 0.00 47.08 0.00 0.00
0.0019 17.69 0.00 0.00 48.33 0.00 0.00 0.21 50.63 0.00 0.00
0.00097 4.62 0.00 0.00 53.96 0.00 0.00 0.00 27.08 0.00 0.00
0.00048 0.00 0.00 0.00 54.17 0.00 0.00 3.54 18.33 0.00 0.00
The values indicated in the table 0.00 demonstrated that don’t have any inhibition on biofilm formation.
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C. articulatus EO that exerted bactericide/fungicide
action against all oral microorganisms studied. The
mode of action observed for C. articulatus EO on the
microorganisms studied can be related to the possible
mechanisms of action presented by its major compo-
nents, a- and b-pinene (Table 5) that showed be able
to destroy cell integrity, and inhibit respiration and
the ion transport processes, leading to cell death [32].
Besides, the C. articulatus compounds presented a consi-
derable antibacterial effect, especially on a methicilline-
resistant Staphylococcus aureus and on Gram-positive and
Gram-negative bacteria [33].
Regard to the inhibition of biofilm formation in the
presence of 1 mg/mL of EOs and fractions (Table 6), the
fraction F2LS and the oils from A. gratissima and C.
articulatus demonstred the highest inhibition, respectively,
on F. nucleatum (62.29%) and P. gingivalis (44.41%), S. mitis
(9%) and C. albicans (28.08%) and S. sanguis (63.96%). Since
no significative difference (p ≤ 0,05) was observed between
the action of the C. articulatus crude oil and the fraction
F2LS against F. nucleatum and P. gingivalis biofilms, the
crude oils from C. articulatus and A. gratissima was chosen
for further assays in the range of 0.0048 – 1 mg/mL
(Table 7). In this condition, A. gratissima inhibited the
A B C
D E F
G H I
J K L
M N O
Figure 1 Scanning electron micrographs of biofilms - 7.500x. (A) C. albicans; (B) C. albicans in the presence of C. articulatus oil; (C) C. albicans
in the presence of Nystatin; (D) F. nucleatum; (E) F. nucleatum in the presence of C. articulatus oil; (F) F. nucleatum in the presence of
chlorhexidine digluconate. (G) P. gingivalis; (H) P. gingivalis in the presence of C. articulatus oil; (I) P. gingivalis in the presence of chlorhexidine
digluconate; (J) S. mitis; (K) S. mitis in the presence of A. gratissima oil; (L) S. mitis in the presence of chlorhexidine digluconate; (M) S. sanguis;
(N) S. sanguis in the presence of C. articulatus oil; (O) S. sanguis in the presence of chlorhexidine digluconato.
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formation of S. mitis biofilm only at 1 mg/mL (9%),
even though this activity was superior to that of the
chlorhexidine. On the other hand, the biofilm inhib-
ition by C. articulatus oil was proportional to the
concentration employed, and also similar or superior
to standards used.
Scanning electronic microscopy (SEM)
Morphological alterations in the microorganisms cells and
biofilm arrangement exposed to the EOs were investigated
by SEM (Figure 1). Through the SEM images was possible
to observe reduction of biofilm formation and changes in
the conformational structure probably due to a decrease
in the cells adherence and consequently in the bio-
film formation. These changes were also observed by
Galvão et al. [34] whose tested the action of the EOs
and bioactive fractions against S. mutans. However,
apparently the EOs do not appear to have caused
changes at cellular level. The decrease in the ability
to form biofilm can be explained by the occurrence
of various resistance mechanisms, which are still not
completely understood given by the expression of resist-
ance genes, and which can be attributed to a decrease in
the rate of cell growth, particularly to those situated close
to the adherence surface [35].
Chemical composition of the active EOs and fractions
The major compounds identified in the most active oils and
fractions are shown in Table 5. The analysis showed
the presence of derived from aliphatic alchools in the
C. sativum oil such as 1-decanol, E-2-decen-1-ol, 2
dodecen-1-ol, E-2-tetradecen-1-ol, E-3-hexen-1-ol,
previously described in this aromatic specie commonly used
in Brazilian culinary [36]. Anti-Candida activity of these
compounds was comproved by Furletti et al. [25], which
tested standards and correlated the activity to Z-2-hexen-ol,
E-2-hexen-ol, E-3-hexen-ol and 1-decanol.
The main compounds identified in the other active oils
were b-pinene, E-pinocamphone, E-caryophyllene, E-
pinocarveol acetate and guaiol in A. gratissima and,
a-pinene, a-bulnesene, E-pinocarveol and a-copaene in
C. articulatus. Regarding to these compounds several
authors have already shown their efficacy against both
Gram-positive and Gram-negative bacteria [37-40].
The action mechanisms of the EOs and its compounds
are not yet fully elucidated, but includes the inhibition of
proton motive force and electron transfer and, consequently
inhibition of the respiratory chain, mechanism of transport
and decrease in substrate oxidation and membrane damage,
leading to cell death [41-44]. Further studies should
be developed in order to investigate the mechanisms
by which the oils and their compounds acted on the oral
microorganisms in the present study.
Conclusion
The action of C. sativum EO against planktonic cells of
C. albicans stood out from others EOs showing the
lowest MIC values against the oral microorganisms
investigated. The crude C. articulatus oil showed the
highest inhibition on the cells adherence and consequently
in the biofilms formation. The oils from these plants can
be considered as new sources of antibacterial agents with
great potential against oral pathogens.
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